These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 26163635

  • 1. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
    Bahgat NA, Kamal MM, Abdelaziz AO, Mohye MA, Shousha HI, ahmed MM, Elbaz TM, Nabil MM.
    Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
    [Abstract] [Full Text] [Related]

  • 2. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
    Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N, Ben Mami N, Saffar H, Trabelsi A, Triki H, Chouchane L.
    Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM, Omran D, Marie MS, Abdelrazek M, Salama A, El Essawey R, Mobarak L, Maklad S, Omar A.
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [Abstract] [Full Text] [Related]

  • 5. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM, Hetta HF, Koneru G, Ammar M, Shafik EA, Mohareb DA, Abbas El-Masry M, Ramadan HK, Abu Rahma MZ, Fawzy MA, Fathy M.
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [Abstract] [Full Text] [Related]

  • 6. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I, Zidi S, Mouelhi L, Ghazoueni E, Brochot E, Almawi WY, Loueslati BY.
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.  PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.
    Al-Qahtani AA, Al-Anazi MR, Al-Zoghaibi FA, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalak H, Al-Ahdal MN.
    Ann Hepatol; 2019 Jan; 15(6):824-833. PubMed ID: 27740515
    [Abstract] [Full Text] [Related]

  • 10. IL-10 Polymorphisms and Haplotypes Predict Susceptibility to Hepatocellular Carcinoma Occurrence in Patients with Hepatitis C Virus Infection from Northeast India.
    Barooah P, Saikia S, Kalita MJ, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S.
    Viral Immunol; 2020 Jan; 33(6):457-467. PubMed ID: 32352886
    [Abstract] [Full Text] [Related]

  • 11. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM, Metwally SS, Farag RE, Lotfy ZF, AbdelTwab HE.
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis.
    Talaat RM, Elsharnoby S, Abdelkhalek MS, El-Shenawy SZ, Elmasry S.
    Immunol Invest; 2022 Apr; 51(3):688-704. PubMed ID: 33445993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM, Ahmed AI, Mosaad NA, Hassan MM, Mahmoud SH.
    Asian Pac J Cancer Prev; 2019 Nov 01; 20(11):3479-3485. PubMed ID: 31759375
    [Abstract] [Full Text] [Related]

  • 15. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
    Dai CY, Chuang WL, Hsieh MY, Lee LP, Hou NJ, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.
    Transl Res; 2006 Sep 01; 148(3):128-33. PubMed ID: 16938650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U.
    Int J Cancer; 2012 Mar 15; 130(6):1470-5. PubMed ID: 21500195
    [Abstract] [Full Text] [Related]

  • 19. Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus.
    Abbott WG, Rigopoulou E, Haigh P, Cooksley H, Mullerova I, Novelli M, Winstanley A, Williams R, Naoumov NV.
    Liver Int; 2004 Apr 15; 24(2):90-7. PubMed ID: 15078471
    [Abstract] [Full Text] [Related]

  • 20. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L, Sonzogni L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Leveri M, Cividini A, Mondelli MU, Civardi E, Silini EM.
    Int J Cancer; 2003 Apr 10; 104(3):310-7. PubMed ID: 12569554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.